Growing resistance to antimicrobials has become one of the most important problems of the 21 st century. The development of new antibiotics is a time-consuming process involving huge financial resources. An alternate approach is proper utilization of the existing antibiotics through the surveillance of resistance. An important component of surveillance is the informatics tool for collection, management and analysis of antimicrobial resistance susceptibility testing data. Based on the scope, antimicrobial resistance surveillance resistance tools can be broadly classified as collectors and integrators.
Antimicrobial resistance (AMR) is a global crisis, and it is estimated that approximately 0.7 million people die every year from drug-resistant strains of microbes. The number will increase to 10 million by 2050, surpassing cancer (8.2 million deaths per year) 1 . Largest contributors of resistance are developing countries where the burden of infectious diseases is high 2 . Increased resistance has jeopardized our ability to treat simple infections leading to prolonged hospital stays, higher mortality and increased treatment costs 3 . With the emergence of superbugs, resistance to the last resort antibiotics has been observed 4 . Discovery of new antibiotics is a timeconsuming process involving the requirement of huge financial resources 5 . An alternate solution to the problem is optimum utilization of existing antibiotics through the surveillance of antimicrobial resistance data. An important component of surveillance is the informatics tool for capturing, storage and analysis of antimicrobial resistance susceptibility testing (AMST) data. The article discusses development of i-AMRSS by the Indian Council of Medical Research (ICMR) for management and analysis of AMR data from different laboratories.
Existing surveillance system
Based on the scope, informatics solutions for AMR can be classified into two groups -the collectors and Integrators. Collectors are laboratory-based tools used by individual laboratories for capturing and monitoring AMST data. These are easily installable, platform dependent, customizable and are designed with a view to collect extensive data. For example, WHONET 6 , a Windows-based software tool developed by the WHO collaborating centre and endorsed by the WHO. It is being used worldwide by many laboratories for management and analysis of AMST. Other examples of collectors include AMWeb 7 , a web-based tool launched by Public Health England and British Society for Antimicrobial Chemotherapy.
Integrators are employed to compile data from collectors at various laboratories. These have limited customization and are designed to collect limited set of variables common/shared across different data sources. Examples include Japan Nosocomial Infections Surveillance (JANIS) 8 , the European Antimicrobial Resistance Surveillance Network 9 and the National Antimicrobial Resistance Monitoring System 10 from Japan, Europe and the USA, respectively.
Although used worldwide, some of the limitations of collectors include issues with data security, integrity, confidentiality and corruption in shared computational resource settings, limited client-server architecture, platform dependence such as limitation in installation and data entry from other platforms, and lack of data validation. Some limitations of integrators include closed source with constrained capability for adding new modules, lack of data validation, limited clientserver architecture along with restricted ability to enforce uniform standards for data collection, and analysis across the network. To overcome the limitations, a hybrid solution (Figure) that can bridge individual laboratories and hospitals to complete picture of AMR in the country would be required. Some of the desirable qualities of the hybrid AMR surveillance tool are use of latest technologies, freely available in the public domain, standardization in data collection and analysis, customization, scalability and extensibility, built-in tools for real-time data analysis, and import and export AMST data in standardized data exchange format.
Hybrid surveillance tool in India
As per the National Action Plan on antimicrobial resistance, India is among the nations with the highest burden of bacterial infections 11 . The crude 
Applications of i-AMRSS in AMR research
i-AMRSS is suitable for capturing the AMST data in developing countries to project a fair picture of nation-wide resistance pattern. It will facilitate genomic studies by identifying priority pathogens showing exceptionally high resistance. i-AMRSS is a web-based tool and can be accessed free. A demo version of the tool is available at http://bic.icmr.org. in/amr/.
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Modules available on i-AMRSS for AMST data collection, storage and analysis
i-AMRSS is a user-friendly web interface to collect AMST data from various laboratories in the network. Registered users can upload AMST data which are validated by expert microbiologists. After successful validation, tables and graphs depicting isolation rates and resistance patterns are generated. A brief description of available modules is given in the Table. The tool has built-in reporting modules for different stakeholders. It enforces standardization of 
